These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36931171)

  • 41. Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas.
    Hua W; Yuan A; Zheng W; Li C; Cui J; Pang Z; Zhang L; Li Z; Goll R; Cui G
    Pathol Res Pract; 2016 Feb; 212(2):106-12. PubMed ID: 26724144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of Treg Functions by the Ubiquitin Pathway.
    Montauti E; Fang D
    Adv Exp Med Biol; 2021; 1278():47-62. PubMed ID: 33523442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Significance of immunoregulatory T cells in different stages of breast cancer patients.
    Abo-Elenein A; Elgohary SE; Hashish A; El-Halaby E
    Egypt J Immunol; 2008; 15(2):145-52. PubMed ID: 20306697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural aspects of the FOXP3 regulatory complex as an immunopharmacological target.
    Zhou Z; Song X; Berezov A; Li B; Greene MI
    Int Immunopharmacol; 2009 May; 9(5):518-20. PubMed ID: 19539569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FOXP3 expression and nodal metastasis of breast cancer.
    Gökmen-Polar Y; Thorat MA; Sojitra P; Saxena R; Badve S
    Cell Oncol (Dordr); 2013 Oct; 36(5):405-9. PubMed ID: 23996727
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
    Li F; Zhao Y; Wei L; Li S; Liu J
    Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comprehensive bioinformatics analysis of FOXP3 in nonsmall cell lung cancer.
    Zhu J; Li Z; Chen J; Li W; Wang H; Jiang T; Ma Y
    Medicine (Baltimore); 2022 Dec; 101(50):e32102. PubMed ID: 36550816
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The emerging role of transcription factor FOXP3 in thyroid cancer.
    Gong Z; Jia H; Xue L; Li D; Zeng X; Wei M; Liu Z; Tong MCF; Chen GG
    Rev Endocr Metab Disord; 2022 Jun; 23(3):421-429. PubMed ID: 34463908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic blockade of Foxp3 in experimental breast cancer models.
    Moreno Ayala MA; Gottardo MF; Imsen M; Asad AS; Bal de Kier Joffé E; Casares N; Lasarte JJ; Seilicovich A; Candolfi M
    Breast Cancer Res Treat; 2017 Nov; 166(2):393-405. PubMed ID: 28756536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast.
    Lal A; Chan L; Devries S; Chin K; Scott GK; Benz CC; Chen YY; Waldman FM; Hwang ES
    Breast Cancer Res Treat; 2013 Jun; 139(2):381-90. PubMed ID: 23712790
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.
    Douglass S; Meeson AP; Overbeck-Zubrzycka D; Brain JG; Bennett MR; Lamb CA; Lennard TW; Browell D; Ali S; Kirby JA
    J Pathol; 2014 Sep; 234(1):74-85. PubMed ID: 24870556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NAC.
    Kaewkangsadan V; Verma C; Eremin JM; Cowley G; Ilyas M; Eremin O
    BMC Cancer; 2018 Feb; 18(1):123. PubMed ID: 29390966
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment.
    Ma GF; Miao Q; Liu YM; Gao H; Lian JJ; Wang YN; Zeng XQ; Luo TC; Ma LL; Shen ZB; Sun YH; Chen SY
    Br J Cancer; 2014 Mar; 110(6):1552-60. PubMed ID: 24548868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer.
    West NR; Kost SE; Martin SD; Milne K; Deleeuw RJ; Nelson BH; Watson PH
    Br J Cancer; 2013 Jan; 108(1):155-62. PubMed ID: 23169287
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alternative Splicing of FOXP3-Virtue and Vice.
    Mailer RKW
    Front Immunol; 2018; 9():530. PubMed ID: 29593749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
    Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
    Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FOXP3 and CXCR4-positive regulatory T cells in the tumor stroma as indicators of tumor immunity in the conjunctival squamous cell carcinoma microenvironment.
    Tagami M; Kakehashi A; Katsuyama-Yoshikawa A; Misawa N; Sakai A; Wanibuchi H; Azumi A; Honda S
    PLoS One; 2022; 17(3):e0263895. PubMed ID: 35358193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interaction of cancer cell-derived Foxp3 and tumor microenvironment in human tongue squamous cell carcinoma.
    Li K; Huang SH; Lao XM; Yang L; Liao GQ; Liang YJ
    Exp Cell Res; 2018 Sep; 370(2):643-652. PubMed ID: 30040923
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting FOXP3 Tumor-Intrinsic Effects Using Adenoviral Vectors in Experimental Breast Cancer.
    Nicola Candia AJ; Garcia Fallit M; Peña Agudelo JA; Pérez Küper M; Gonzalez N; Moreno Ayala MA; De Simone E; Giampaoli C; Casares N; Seilicovich A; Lasarte JJ; Zanetti FA; Candolfi M
    Viruses; 2023 Aug; 15(9):. PubMed ID: 37766222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.
    Yu Y; Huang R; Zong X; He X; Mo W
    BMC Cancer; 2016 Jul; 16():397. PubMed ID: 27389040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.